mitral valve repair

Devices & Diagnostics

CardioMech Snags $13M For Its Mitral Valve Repair Tech

Medical device startup CardioMech raised $13 million to advance the development and validation of its flagship device, which is designed to treat degenerative mitral valve regurgitation. The catheter-based device seeks to offer an uncomplicated, direct procedure for patients eligible for open-heart surgery as well as those considered eligible for the surgery.